Gefitinib (ZD1839) (INN, / ɡ ɛ ˈ f ɪ t ᵻ n ɪ b /, trade name Iressa, marketed by AstraZeneca and Teva), is a drug used for certain breast, lung and other cancers.
This page contains brief information about gefitinib and a collection of links to more information about the use of this drug, research results, and ongoing clinical ...
Gefitinib. Gefitinib is a cancer treatment marketed under the brand name Iressa. It is not a chemotherapeutic in the traditional sense, since it does not cause the ...
Exposes the medication gefitinib (Iressa), a drug used as monotherapy for lung cancer that has not responded to chemotherapy.
Easy to read patient leaflet for gefitinib. Includes indications, proper use, special instructions, precautions, and possible side effects.
Read about the cancer treatment drug gefitinib, also called Iressa, including what it is, how it works and possible side effects.
Learn about IRESSA® (gefitinib), now approved for first-line treatment of EGFR mutation–positive patients with metastatic NSCLC
Gefitinib comes as a tablet to take by mouth. It is usually taken with or without food once a day. Take gefitinib at around the same time every day.
Information about a drug called Gefitinib (Iressa®), which may be used to treat non-small cell lung cancer (NSCLC) or other types of cancer as part of a research trial
Introduction . Gefitinib is a selective tyrosine kinase receptor inhibitor used in the therapy of non-small cell lung cancer. Gefitinib therapy is ...